Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug
Journal of Materials Chemistry B · 2025 · 13 (1) · 256-263
DOI: 10.1039/d4tb01798f ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Mingxing Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China. rongtiannuclear@126.com. Hauptthemen laut MEDLINE: Carbocyanines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Malignant tumors pose substantial treatment challenges due to their heterogeneity, metastatic potential, and therapeutic resistance, underscoring the urgent need for more effective treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China. rongtiannuclear@126.com.
- Department of Nuclear Medicine and Clinical Nuclear Medicine Research Lab, West China Hospital, Sichuan University, Chengdu, China.
- Nuclear Power Institute of China, National Engineering Research Center of Isotope and Medicine, and Radioisotope Engineering Technology Research Center of Sichuan, Chengdu, China.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
ORCID-Profile: Yingwei Wang, Rong Tian
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, M., Wang, W., Wang, Y., Wang, R., Pan, L., Li, X., Li, B., Zhang, J., Wang, R., Zhang, Y., & Tian, R. (2025). Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug. Journal of Materials Chemistry B, 13(1), 256-263. https://doi.org/10.1039/d4tb01798f
Vancouver
Huang M, Wang W, Wang Y, Wang R, Pan L, Li X, et al. Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug. Journal of Materials Chemistry B. 2025;13(1):256-263. doi:10.1039/d4tb01798f
BibTeX
@article{Huang2025,
author = {Huang, Mingxing and Wang, Weichen and Wang, Yingwei and Wang, Rang and Pan, Lili and Li, Xin and Li, Bo and Zhang, Jingsong and Wang, Ruoxiang and Zhang, Yi and Tian, Rong},
title = {Advancing cancer therapy with a heptamethine carbocyanine dye-conjugated radionuclide drug},
journal = {Journal of Materials Chemistry B},
year = {2025},
volume = {13},
number = {1},
pages = {256--263},
doi = {10.1039/d4tb01798f}
}
EUVIMED